As reported in last week's Technology Briefing, chemokine research has become a hot area since the discovery of chemokine receptors as co-factors in HIV infection. However, a shortcoming of using chemokines themselves as drugs is their short half-life of less than 10 minutes.

Researchers at the Bowman Gray School of Medicine at Wake Forest University